CCL2 and head and neck squamous cell carcinoma: Moreover, ELISA assay and qRT-PCR demonstrated that CCL2 did not upregulate the levels of other functional ligands of CCR4, including CCL17 or CCL22, in HNSCC (Supplementary Fig. 2).